Primus In News
HydraFacials to botox: How India's wedding rush is powering a beauty boom
12-10-2025
Nilaya Varma, Co-founder and Group CEO, Primus Partners, highlights that India’s aesthetic injectable and non-invasive treatment markets, valued at $232.9 million and $1.9 billion respectively in 2023, are set for rapid growth. Driven by rising awareness, technological innovation, and medical tourism, these sectors are expected to grow at compound annual growth rates of 15% and 19.2% through 2030.
Explore Related Insights
- How Cloud and AI will shape India's digital transformation Journey in 2025
- Will Tesla’s India Entry Shake Up Tata, Mahindra, And Other Local EV Makers? Here’s What Experts Say
- Building Tomorrow's Tech Hub: Rajasthan's IT & Startup Pre-Summit Takes Centre Stage
- Why are Indian markets unaffected by recent slump in Wall Street? Here are four likely reasons
